Stamford: SpringWorks Therapeutics, Inc., a healthcare company of Merck, has received marketing authorization from the ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Thursday’s market has seen significant movements among various stocks, with some experiencing sharp declines while others are rallying. In the mega-cap and large-cap categories, companies like ...

While phase 1 data suggest the novel vaccine can boost immunity and reduce relapse in pancreatic and colorectal cancer, experts remain cautious at this initial stage.

Merck & Co Inc. saw its shares climb, signaling a shift toward value and income in the market. The stock opened at $84.38 and maintained this as its low, showing a strong floor of support from the ...

“Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn’t significantly changed since the 1980s,” Professor Thomas Powles, director of Barts Cancer Institute ...

A telephone-based intervention resulted in significant weight loss for breast cancer patients with overweight or obesity in a ...

Experts said the approval of the new treatment combination would bring a ‘fundamental shift’ in care for patients with late-stage disease.

MDMA (Molly, ecstasy) is an empathogen widely used as a club drug that may become a future treatment for PTSD. Many respond well to it.

The AAP published its own vaccine schedule in a break from federal guidance. HHS secretary RFK Jr. took to social media to respond.

After six days of gains, shares dropped, reflecting mixed momentum. See insights on earnings, cost-cutting, and analyst ...